RSS

CAR T-cells

Clinical-stage biopharmaceutical company, Autolus, has presented data for its pan-checkpoint blocking technology at the American Society of Hematology (ASH) annual meeting in Atlanta. more

News

Clinical-stage biopharmaceutical company, Autolus has announced the publication of an article detailing a unique targeting strategy for the treatment of patients with T-cell lymphomas in Nature Medicine. more

News